Remedy Robotics Partners with Mission Thrombectomy
Remedy Robotics has entered a strategic partnership with Mission Thrombectomy, a leading clinician network dedicated to accelerating access to endovascular thrombectomy in stroke.
The partnership aims to expand access to thrombectomy in the U.S. and globally using the Remedy Robotics N1 system, a remotely operable endovascular robot that combines proprietary hardware and AI-enabled software.
- Remedy Robotics announced the partnership with the Society of Vascular and Interventional Neurology’s Mission Thrombectomy.
- This marks the second partnership for the company in recent weeks, following a deal with the Australian Stroke Alliance.
The company touts N1 as the world’s first remotely operable endovascular robot, enabling faster, safer and more effective innovation in cardiovascular conditions.
Author's summary: Remedy Robotics partners with Mission Thrombectomy to expand thrombectomy access.
More News
- Eintracht Frankfurt Borussia Dortmund 28 10 2025 Live Score and Match Summary
- Vance says troops will be paid as pressure builds to end shutdown
- Trump administration quietly purges ICE leaders in five cities, including Denver: Sources
- The museum and the mass grave: How colonial powers curate our pain
- The Angel Ball Honors Tina Knowles
- Al Nassr Al-Ittihad Jeddah 28 10 2025 Live Score and Match Summary
- Tomago Aluminium is more than just a smelter, it's a strategic asset
- The Most Dazzling Looks From The Angel Ball's 2025 Red Carpet
- Move Over Protein. Here’s One of the Hottest Food Trends for 2026, Experts Say
- Fiddler Scott Woods doesn't dip his bow into politics